Update on Novel Therapeutics for Primary CNS Lymphoma
Primary central nervous system lymphoma (PCNSL) is a rare lymphoma isolated to the central nervous system or vitreoretinal space. Standard treatment consists of cytotoxic methotrexate-based chemotherapy, with or without radiation. Despite high rates of response, relapse is common, highlighting the n...
Guardado en:
Autores principales: | Lauren R. Schaff, Christian Grommes |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af9b30bbf2c640b7ae8102c15224e36d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
por: Casey L. Anthony, et al.
Publicado: (2021) -
Emerging Therapeutic Landscape of Peripheral T-Cell Lymphomas Based on Advances in Biology: Current Status and Future Directions
por: Maliha Khan, et al.
Publicado: (2021) -
A Validated HPLC-MS/MS Method for Quantification of Methotrexate and Application for Therapeutic Drug Monitoring in Children and Adults with Non-Hodgkin Lymphoma
por: Feng Z, et al.
Publicado: (2021) -
THE TRANSFORMATION OF THE NOVEL IN THE CONTEXT OF KİRALIK KONAK, KÖR BAYKUŞ AND BİR KIŞ GECECİ EĞER BİR YOLCU
por: Fethi DEMİR, et al.
Publicado: (2021) -
Novel treatments for osteoarthritis: a recent update
por: Wu Y, et al.
Publicado: (2018)